相关实验视频
Updated: May 21, 2025

Enhancing Tumor Content through Tumor Macrodissection
Published on: February 12, 2022
类风湿性关节炎患者的扩散性大B细胞淋巴瘤与B细胞驱动因素的升高有关,包括CXCL13
Nora Euler1, Erik Hellbacher2, Erik Af Klint1
1Division of Rheumatology, Department of Medicine Solna, Karolinska Institutet and Karolinska University Hospital, Center for Molecular Medicine, Stockholm, Sweden.
患有类风湿性关节炎 (RA) 患有扩散性大B细胞淋巴瘤 (DLBCL) 的患者表现出更高水平的特定炎症标志物. 这些升高的标记物,特别是CXCL13,可能会导致RA患者的B细胞激活和淋巴瘤发展.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 类风湿病学 类风湿病学
背景情况:
- 患有类风湿性关节炎 (RA) 的患者面临患扩散性大B细胞淋巴瘤 (DLBCL) 的风险较高.
- 了解RA相关DLBCL所涉及的特定炎症途径对于确定潜在的治疗点至关重要.
研究的目的:
- 为了调查和描述RA患者血液中的炎症概况,RA患者已经开发了DLBCL.
- 为了比较这些炎症标志物和DLBCL的RA患者和没有DLBCL的RA患者之间的自身抗体特征.
主要方法:
- 在RA-DLBCL患者和RA对照者的血液中分析促炎标志物 (TNF,IL-8,CXCL9,APRIL,CXCL13).
- 综合性自身抗体分析,包括类风湿因子,抗CCP2,ACPA细特异性以及其他抗修饰蛋白抗体.
- 测量免疫球蛋白自由光链和C反应蛋白水平.
主要成果:
- 与RA对照组相比,RA-DLBCL患者表现出明显更高的炎症前标记物水平,最显著的是CXCL13.
- 所有RA-DLBCL患者均为自身抗体血清阳性,但在RA-DLBCL和RA对照组之间没有观察到自身抗体特征的显著差异.
- 免疫球蛋白自由光链和C反应蛋白的水平在两组之间是可比的.
结论:
- 患有RA-DLBCL的患者表现出明显的促炎特征,其特征是B细胞相关炎症标志物的水平升高.
- 这些增强的炎症标志物可能在促进B细胞激活和随后的淋巴瘤发展方面发挥重要作用.
- 针对这些特定的炎症途径可以为在RA患者中预防或治疗DLBCL提供新的治疗策略.
更多相关视频
06:35An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
Published on: February 8, 2019
11:06Genome-wide Analysis of HDAC Inhibitor-mediated Modulation of microRNAs and mRNAs in B Cells Induced to Undergo Class-switch DNA Recombination and Plasma Cell Differentiation
Published on: September 20, 2017
相关概念视频
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
The JAK-STAT Signaling Pathway
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Autoimmune Disorders
Concept and Mechanism of Autoimmune Diseases
The immune...
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
B Cell Activation and Differentiation
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...